Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 Aryl 2 Hydroxy Butyric Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101941900A details a novel ruthenium-catalyzed asymmetric hydrogenation route for high-purity ACE inhibitor intermediates, offering significant cost reduction and supply chain stability.
Patent CN101941900A reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity chiral acids, offering significant cost reduction in API manufacturing and enhanced supply chain stability.